| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |